COMMUNIQUÉS West-GlobeNewswire

CytomX’s Varsetatug Masetecan (EpCAM PROBODY® ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer
16/03/2026
- Confirmed response rates in expansion cohorts of 32% at 10 mg/kg Q3W dose and 20% at 8.6 mg/kg Q3W - - Estimated progression free survival of 7.1 months at 10 mg/kg and 6.8 months at 8.6 mg/kg - - Grade 3 diarrhea [...]
Minutes from Extraordinary General Meeting
16/03/2026
An extraordinary general meeting of PCI Biotech Holding ASA (“the Company”) took place today, 16 March 2026. All the matters on the agenda were approved in accordance with the proposals set out in the meeting notice, [...]
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
16/03/2026
Financing demonstrates conviction in oligomer-selective approach and follows strong preclinical data, including in vitro , in vivo and non-human primate study results, that support development candidates in Acumen’s [...]
Doctomatic Appoints Tech Veteran Bill Josko as Head of Americas to Scale AI-Driven Remote Patient Monitoring
16/03/2026
BARCELONA, Spain, March 16, 2026 (GLOBE NEWSWIRE) -- Doctomatic, an AI-native platform for remote patient management, announces the appointment of Bill Josko as Head of Americas. Josko, a seasoned executive with more [...]
Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01
16/03/2026
STAFFORD, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
Novo Nordisk A/S - share repurchase programme
16/03/2026
Bagsværd, Denmark, 16 March 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
16/03/2026
COPENHAGEN, Denmark, March 16, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on March 12, 2026, under which the Company will repurchase shares for an amount up [...]
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
16/03/2026
ZUG, Switzerland, March 16, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical [...]
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
16/03/2026
ZUG, Switzerland, 16 March, 2026 -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in [...]
Dvorak Botanicals Launches Low-Dose Hemp-Derived THC Gummies Focused on Mindful Consumption
16/03/2026
Atlanta, GA, March 16, 2026 (GLOBE NEWSWIRE) -- Dvorak Botanicals, a new premium hemp-derived THC brand founded by Atlanta-based entrepreneur Dane Dvorak, has launched with a focus on controlled-dose hemp products that [...]
GN Store Nord A/S enters into agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion
16/03/2026
Today, GN Store Nord A/S (“GN”) has entered into a definitive agreement for the sale of GN’s Hearing business to Amplifon S.p.A. (“Amplifon”), a leading global hearing care retailer. The transaction values the Hearing [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
16/03/2026
ZUG, Switzerland, March 16, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to the purchase of ordinary shares by a member of the Company’s Board of Directors. Attachments notification-of-managers-transaction [...]
EssilorLuxottica and Dolce&Gabbana further strengthen their partnership through 2050
16/03/2026
EssilorLuxottica and Dolce&Gabbana further strengthen their partnership through 2050 Paris, France and Milan, Italy (16 March 2026) - EssilorLuxottica and Dolce&Gabbana announced today the extension of the [...]
EssilorLuxottica et Dolce&Gabbana renforcent leur partenariat jusqu’en 2050
16/03/2026
EssilorLuxottica et Dolce&Gabbana renforcent leur partenariat jusqu’en 2050 Paris, France et Milan, Italie (16 mars 2026) - EssilorLuxottica et Dolce&Gabbana annoncent l’extension de leur accord de licence jusqu [...]
SAFE - Modification de la composition du Conseil d'Administration
16/03/2026
Modification de la composition du Conseil d'Administration Fleurieux-sur-l’Arbresle - France - le 16 mars 2026 à 8h. SAFE Group annonce des évolutions significatives au sein de son Conseil d'Administration. Cooptation d [...]
OSE Immunotherapeutics Announces its 2026 Financial Calendar
16/03/2026
Nantes, France, March 16, 2026 – 7:30am CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced its financial calendar for 2026. Information Date* 2025 Full-Year Financial Update and Statements [...]
OSE Immunotherapeutics annonce son calendrier financier pour 2026
16/03/2026
Nantes, France, 16 mars 2026 – 7h30 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) annonce aujourd’hui son calendrier financier pour 2026. Information Date* Résultats financiers annuels 2025 29 [...]
Idorsia announces management change
16/03/2026
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – March 16, 2026 Idorsia Ltd (SIX: IDIA) announces that Dr Srishti Gupta and the Board of Idorsia have mutually agreed that Srishti will step down from [...]
BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start
16/03/2026
Ad hoc announcement pursuant to Art. 53 LR BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP), caused by [...]

Pages